Latest Capital Markets News

Page 12 of 175
Tamboran Resources is poised to deliver first gas sales from its Beetaloo Basin pilot project, backed by a robust balance sheet and strategic partnerships aiming to slash drilling costs.
Maxwell Dee
Maxwell Dee
31 Aug 2026
CurveBeam AI’s FY2026 results show a 28% revenue decline and a 12% increase in net loss, while advancing its China commercialisation and robotic surgery integration strategies. The company also announced a $6-7 million capital raise post-year-end.
Ada Torres
Ada Torres
31 Aug 2026
BluGlass Limited reported a 5% reduction in its net loss to A$10.39 million for FY26 despite a 10% revenue dip, boosted by new US defence and industry contracts and a significant capital raise to fund growth.
Sophie Babbage
Sophie Babbage
31 Aug 2026
Tartana Minerals has lodged a cleansing prospectus to enable ASX quotation of over 129 million options linked to a $4.5 million placement, with exercise price set at 5.5 cents and expiry in April 2029.
Maxwell Dee
Maxwell Dee
28 Aug 2026
Constellation Technologies (ASX:CT1) reported a 5% revenue decline to $1.71 million and a $458,246 net loss for FY26, weighed down by delayed hardware deployments and increased expenses. Recurring subscription revenue grew 22%, reflecting ongoing customer engagement.
Sophie Babbage
Sophie Babbage
28 Aug 2026
Green & Gold Minerals posted a $886,828 loss for FY2026 amid a transformative year marked by its ASX listing and expansion into base metals exploration with the Herberton acquisition.
Maxwell Dee
Maxwell Dee
27 Aug 2026
Almasar Minerals Limited (ASX:AMK) is launching an IPO to fund early-stage exploration across five licences in Saudi Arabia’s Arabian Shield, targeting gold and copper mineralisation.
Maxwell Dee
Maxwell Dee
27 Aug 2026
Rhythm Biosciences marked its transition to commercialisation with first sales of ColoSTAT® and geneType™ tests, despite a 55% increase in loss to $5.93 million. The company expanded market access and secured manufacturing agreements, while NHS England began evaluating ColoSTAT® for bowel cancer screening.
Ada Torres
Ada Torres
27 Aug 2026
Clinuvel Pharmaceuticals marked its tenth consecutive profit with stable revenues and rising cash reserves, while accelerating U.S. expansion including a Nasdaq uplisting and potential ASX delisting.
Victor Sage
Victor Sage
27 Aug 2026
Careteq Limited (ASX: CTQ) reported a $398K net loss for FY26 amid a strategic reset that included selling its Embedded Health Solutions business and repaying all debt. The company now pivots fully to growing its HMR Referrals platform with $3.19 million cash on hand.
Ada Torres
Ada Torres
27 Aug 2026
Pengana Capital Group reported a statutory loss of $5.6 million for FY26 despite a 14% rise in funds under management, driven by upfront costs linked to new product launches and expanding private credit platforms.
Claire Turing
Claire Turing
26 Aug 2026
Ingenia Communities Group has unveiled a $2.185 per share acquisition offer for Peet Limited, aiming to create Australia’s largest pure-play living sector platform with enhanced scale, diversification, and market presence.
Eva Park
Eva Park
26 Aug 2026

Browse the archive

Full archive